Stock Scorecard
Stock Summary for Bio-Techne Corp (TECH) - $68.72 as of 11/20/2024 8:46:34 PM EST
Total Score
10 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TECH
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TECH
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TECH
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TECH
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TECH (50 out of 90)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 2 |
Latest News for for TECH
Financial Details for TECH
Company Overview |
|
|---|---|
| Ticker | TECH |
| Company Name | Bio-Techne Corp |
| Country | USA |
| Description | Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota. |
| Sector Name | LIFE SCIENCES |
| Industry Name | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 1/30/2025 |
Stock Price History |
|
| Last Day Price | 68.72 |
| Price 4 Years Ago | 78.11 |
| Last Day Price Updated | 11/20/2024 8:46:34 PM EST |
| Last Day Volume | 1,493,334 |
| Average Daily Volume | 989,838 |
| 52-Week High | 85.39 |
| 52-Week Low | 60.97 |
| Last Price to 52 Week Low | 12.71% |
Valuation Measures |
|
| Trailing PE | 71.13 |
| Industry PE | 120.49 |
| Sector PE | 40.32 |
| 5-Year Average PE | 67.90 |
| Free Cash Flow Ratio | 58.24 |
| Industry Free Cash Flow Ratio | 15.59 |
| Sector Free Cash Flow Ratio | 27.97 |
| Current Ratio Most Recent Quarter | 4.56 |
| Total Cash Per Share | 1.18 |
| Book Value Per Share Most Recent Quarter | 13.46 |
| Price to Book Ratio | 5.02 |
| Industry Price to Book Ratio | 5.50 |
| Sector Price to Book Ratio | 20.88 |
| Price to Sales Ratio Twelve Trailing Months | 9.07 |
| Industry Price to Sales Ratio Twelve Trailing Months | 20.11 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 158,892,000 |
| Market Capitalization | 10,919,058,240 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 11/8/2024 |
| Last Dividend Amount | 0.08 |
| Current Dividend Amount | 0.08 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.32 |
| Trailing Annual Dividend Yield | 0.47% |
| Forward Annual Dividend Rate | 0.32 |
| Forward Annual Dividend Yield | 0.47% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 0.35% |
| 5-Year Average Dividend Yield | 0.41% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 11.50% |
| Dividend Payout Ratio | 33.68% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -32.30% |
| Annual Earnings Growth | -41.07% |
| Reported EPS 12 Trailing Months | 0.95 |
| Reported EPS Past Year | 0.42 |
| Reported EPS Prior Year | 1.78 |
| Net Income Twelve Trailing Months | 150,712,000 |
| Net Income Past Year | 168,105,000 |
| Net Income Prior Year | 285,263,000 |
| Quarterly Revenue Growth YOY | 4.50% |
| 5-Year Revenue Growth | 10.86% |
| Operating Margin Twelve Trailing Months | 0.18 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 187,540,000 |
| Total Cash Past Year | 152,863,000 |
| Total Cash Prior Year | 204,310,000 |
| Net Cash Position Most Recent Quarter | -131,460,000 |
| Net Cash Position Past Year | -166,137,000 |
| Long Term Debt Past Year | 319,000,000 |
| Long Term Debt Prior Year | 350,000,000 |
| Total Debt Most Recent Quarter | 319,000,000 |
| Equity to Debt Ratio Past Year | 0.87 |
| Equity to Debt Ratio Most Recent Quarter | 0.87 |
| Total Stockholder Equity Past Year | 2,068,850,000 |
| Total Stockholder Equity Prior Year | 1,966,516,000 |
| Total Stockholder Equity Most Recent Quarter | 2,138,650,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 245,030,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.54 |
| Free Cash Flow Past Year | 236,104,000 |
| Free Cash Flow Prior Year | 216,149,000 |
Options |
|
| Put/Call Ratio | 1.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.56 |
| MACD Signal | 0.35 |
| 20-Day Bollinger Lower Band | 68.34 |
| 20-Day Bollinger Middle Band | 74.53 |
| 20-Day Bollinger Upper Band | 80.72 |
| Beta | 1.28 |
| RSI | 52.36 |
| 50-Day SMA | 73.35 |
| 150-Day SMA | 79.84 |
| 200-Day SMA | 87.35 |
System |
|
| Modified | 11/19/2024 2:06:20 PM EST |